Questions About Cancer? 1-800-4-CANCER

Myeloproliferative Disorders: Treatment

Information Summaries from PDQ

  • Adult Acute Myeloid Leukemia Treatment (PDQ®)
    [ patient ] [ health professional ]
    Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.
  • Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)
    [ patient ] [ health professional ]
    Expert-reviewed information summary about the treatment of childhood acute myeloid leukemia, myelodysplastic syndromes, and other myeloproliferative disorders.
  • Chronic Myelogenous Leukemia Treatment (PDQ®)
    [ patient ] [ health professional ]
    Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.
  • Chronic Myeloproliferative Neoplasms Treatment (PDQ®)
    [ patient ] [ health professional ]
    Expert-reviewed information summary about the treatment of chronic myeloproliferative neoplasms.
  • Myelodysplastic Syndromes Treatment (PDQ®)
    [ patient ] [ health professional ]
    Expert-reviewed information summary about the treatment of myelodysplastic syndromes.
  • Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®)
    [ patient ] [ health professional ]
    Expert-reviewed information summary about the treatment of myelodysplastic/myeloproliferative neoplasms including chronic/juvenile myelomonocytic leukemias and atypical CML.

Drug Information

  • Drugs Approved for Myeloproliferative Disorders
    This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative disorders. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters. The drug names link to NCI's Cancer Drug Information summaries.

Related Treatment Information

Related Pages